Gary James Leclair, MD | |
3100 Martin Luther King Jr Pkwy, Springfield, OR 97477-7514 | |
(541) 485-2777 | |
(541) 246-2353 |
Full Name | Gary James Leclair |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology - Gynecology |
Location | 3100 Martin Luther King Jr Pkwy, Springfield, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1871518969 | NPI | - | NPPES |
233437 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | LF00001937 (Oregon) | Secondary |
207VG0400X | Obstetrics & Gynecology - Gynecology | MD09743 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Gary James Leclair, MD Po Box 70368, Springfield, OR 97475-0120 Ph: (541) 485-2777 | Gary James Leclair, MD 3100 Martin Luther King Jr Pkwy, Springfield, OR 97477-7514 Ph: (541) 485-2777 |
News Archive
Donald Trump's ego may be the size of his financial empire, but that doesn't mean he's the picture of mental health. The same can be said about the self-esteem of people who are living from paycheck to paycheck, or unemployed. New research from the University of California, Berkeley, underscores this mind-wallet connection.
The American Medical Group Association (AMGA) sent a letter to the White House yesterday asking the President to preserve the ability for its member multispecialty medical groups and integrated health systems to provide advanced imaging services to their patients.
By shedding new light on how cells migrate in the developing brain, researchers at Fred Hutchinson Cancer Research Center also may have found a new mechanism by which other types of cells, including cancer cells, travel within the body.
U.N. High Commissioner for Refugees Antonio Guterrez on Wednesday during a four-day trip to Thailand called on Thailand's government to address the spread of HIV within refugee camps along the Thai-Myanmar border, according to Thailand's deputy government spokesperson Chalermchai Mahakitsiri, AFP/Today Online reports.
ArQule, Inc. today announced the commencement of patient dosing in a Phase 1 clinical trial with ARQ 736, a small molecule inhibitor of the RAF kinases.
› Verified 8 days ago